Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart
The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanism...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 2011-03, Vol.300 (3), p.H820-H835 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | H835 |
---|---|
container_issue | 3 |
container_start_page | H820 |
container_title | American journal of physiology. Heart and circulatory physiology |
container_volume | 300 |
creator | Raddatz, Eric Thomas, Anne-Catherine Sarre, Alexandre Benathan, Messod |
description | The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation. |
doi_str_mv | 10.1152/ajpheart.00827.2010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_855200251</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2285018821</sourcerecordid><originalsourceid>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</originalsourceid><addsrcrecordid>eNpdkc1u1DAURi0EokPhCZCQxYZNM9jX4yReVi1QpApYwDpy7JsZjxJ7sB2peZE-L-5My6IrS9fn3B99hLznbM25hM96f9ihjnnNWAvNGhhnL8iq_EDFpVAvyYqJWlQ1F_KMvElpzxiTTS1ekzPgXAnZtityf-2GASP67PRITfA5un7OLngaBjq5HMwueBudvqA_Lq9_3dBw56xOmC6o9pZux8WEcUku0RxoxG0xq3RA4wZnTqzPNOWIKVHnad5h8UrdVBHD3bJFrzNailMfl-CLc7zpLXk16DHhu8f3nPz5-uX31U11-_Pb96vL28oI1eQKNoLpDVguWlsrUFoo0zMQUjSgpQKG7abcKhvVgjYt6yVYs7GK1xq4BiHOyadT30MMf2dMuZtcMjiO2mOYU9dKCYyB5IX8-Izchzn6stwRUmWELJA4QSaGlCIO3SG6Scel46x7CK17Cq07htY9hFasD4-t535C-995Skn8A0pXllA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>855297985</pqid></control><display><type>article</type><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</creator><creatorcontrib>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</creatorcontrib><description>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00827.2010</identifier><identifier>PMID: 21193588</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antioxidants ; Chick Embryo ; Electron Transport Complex I - antagonists & inhibitors ; Electron Transport Complex I - metabolism ; Electron Transport Complex III - antagonists & inhibitors ; Electron Transport Complex III - metabolism ; Embryos ; Glucose ; Glycogen - metabolism ; Glycolysis - drug effects ; Glycolysis - physiology ; Heart ; Heart - drug effects ; Heart - physiopathology ; Hypoxia - drug therapy ; Hypoxia - metabolism ; Hypoxia - physiopathology ; Iodoacetates - pharmacology ; Lactates - metabolism ; Metabolism ; Methacrylates - pharmacology ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondria, Heart - physiology ; Myocardium - metabolism ; NADPH Oxidases - antagonists & inhibitors ; NADPH Oxidases - metabolism ; NADPH Oxidases - physiology ; NG-Nitroarginine Methyl Ester - pharmacology ; Ornithine - analogs & derivatives ; Ornithine - pharmacology ; Oxidative stress ; Oxidative Stress - drug effects ; Oxidative Stress - physiology ; Poultry ; Reactive Oxygen Species - metabolism ; Reperfusion Injury - drug therapy ; Reperfusion Injury - metabolism ; Reperfusion Injury - physiopathology ; Rotenone - pharmacology ; Thiazoles - pharmacology</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2011-03, Vol.300 (3), p.H820-H835</ispartof><rights>Copyright American Physiological Society Mar 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</citedby><cites>FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21193588$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Raddatz, Eric</creatorcontrib><creatorcontrib>Thomas, Anne-Catherine</creatorcontrib><creatorcontrib>Sarre, Alexandre</creatorcontrib><creatorcontrib>Benathan, Messod</creatorcontrib><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</description><subject>Animals</subject><subject>Antioxidants</subject><subject>Chick Embryo</subject><subject>Electron Transport Complex I - antagonists & inhibitors</subject><subject>Electron Transport Complex I - metabolism</subject><subject>Electron Transport Complex III - antagonists & inhibitors</subject><subject>Electron Transport Complex III - metabolism</subject><subject>Embryos</subject><subject>Glucose</subject><subject>Glycogen - metabolism</subject><subject>Glycolysis - drug effects</subject><subject>Glycolysis - physiology</subject><subject>Heart</subject><subject>Heart - drug effects</subject><subject>Heart - physiopathology</subject><subject>Hypoxia - drug therapy</subject><subject>Hypoxia - metabolism</subject><subject>Hypoxia - physiopathology</subject><subject>Iodoacetates - pharmacology</subject><subject>Lactates - metabolism</subject><subject>Metabolism</subject><subject>Methacrylates - pharmacology</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondria, Heart - physiology</subject><subject>Myocardium - metabolism</subject><subject>NADPH Oxidases - antagonists & inhibitors</subject><subject>NADPH Oxidases - metabolism</subject><subject>NADPH Oxidases - physiology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Ornithine - analogs & derivatives</subject><subject>Ornithine - pharmacology</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Oxidative Stress - physiology</subject><subject>Poultry</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Reperfusion Injury - drug therapy</subject><subject>Reperfusion Injury - metabolism</subject><subject>Reperfusion Injury - physiopathology</subject><subject>Rotenone - pharmacology</subject><subject>Thiazoles - pharmacology</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpdkc1u1DAURi0EokPhCZCQxYZNM9jX4yReVi1QpApYwDpy7JsZjxJ7sB2peZE-L-5My6IrS9fn3B99hLznbM25hM96f9ihjnnNWAvNGhhnL8iq_EDFpVAvyYqJWlQ1F_KMvElpzxiTTS1ekzPgXAnZtityf-2GASP67PRITfA5un7OLngaBjq5HMwueBudvqA_Lq9_3dBw56xOmC6o9pZux8WEcUku0RxoxG0xq3RA4wZnTqzPNOWIKVHnad5h8UrdVBHD3bJFrzNailMfl-CLc7zpLXk16DHhu8f3nPz5-uX31U11-_Pb96vL28oI1eQKNoLpDVguWlsrUFoo0zMQUjSgpQKG7abcKhvVgjYt6yVYs7GK1xq4BiHOyadT30MMf2dMuZtcMjiO2mOYU9dKCYyB5IX8-Izchzn6stwRUmWELJA4QSaGlCIO3SG6Scel46x7CK17Cq07htY9hFasD4-t535C-995Skn8A0pXllA</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>Raddatz, Eric</creator><creator>Thomas, Anne-Catherine</creator><creator>Sarre, Alexandre</creator><creator>Benathan, Messod</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</title><author>Raddatz, Eric ; Thomas, Anne-Catherine ; Sarre, Alexandre ; Benathan, Messod</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c397t-2430a42d138d6929a39cb0235372a5920e8421157982ac80b52dc4d916a21a233</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Antioxidants</topic><topic>Chick Embryo</topic><topic>Electron Transport Complex I - antagonists & inhibitors</topic><topic>Electron Transport Complex I - metabolism</topic><topic>Electron Transport Complex III - antagonists & inhibitors</topic><topic>Electron Transport Complex III - metabolism</topic><topic>Embryos</topic><topic>Glucose</topic><topic>Glycogen - metabolism</topic><topic>Glycolysis - drug effects</topic><topic>Glycolysis - physiology</topic><topic>Heart</topic><topic>Heart - drug effects</topic><topic>Heart - physiopathology</topic><topic>Hypoxia - drug therapy</topic><topic>Hypoxia - metabolism</topic><topic>Hypoxia - physiopathology</topic><topic>Iodoacetates - pharmacology</topic><topic>Lactates - metabolism</topic><topic>Metabolism</topic><topic>Methacrylates - pharmacology</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondria, Heart - physiology</topic><topic>Myocardium - metabolism</topic><topic>NADPH Oxidases - antagonists & inhibitors</topic><topic>NADPH Oxidases - metabolism</topic><topic>NADPH Oxidases - physiology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Ornithine - analogs & derivatives</topic><topic>Ornithine - pharmacology</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Oxidative Stress - physiology</topic><topic>Poultry</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Reperfusion Injury - drug therapy</topic><topic>Reperfusion Injury - metabolism</topic><topic>Reperfusion Injury - physiopathology</topic><topic>Rotenone - pharmacology</topic><topic>Thiazoles - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Raddatz, Eric</creatorcontrib><creatorcontrib>Thomas, Anne-Catherine</creatorcontrib><creatorcontrib>Sarre, Alexandre</creatorcontrib><creatorcontrib>Benathan, Messod</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Raddatz, Eric</au><au>Thomas, Anne-Catherine</au><au>Sarre, Alexandre</au><au>Benathan, Messod</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2011-03</date><risdate>2011</risdate><volume>300</volume><issue>3</issue><spage>H820</spage><epage>H835</epage><pages>H820-H835</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>The ability of the developing myocardium to tolerate oxidative stress during early gestation is an important issue with regard to possible detrimental consequences for the fetus. In the embryonic heart, antioxidant defences are low, whereas glycolytic flux is high. The pro- and antioxidant mechanisms and their dependency on glucose metabolism remain to be explored. Isolated hearts of 4-day-old chick embryos were exposed to normoxia (30 min), anoxia (30 min), and hyperoxic reoxygenation (60 min). The time course of ROS production in the whole heart and in the atria, ventricle, and outflow tract was established using lucigenin-enhanced chemiluminescence. Cardiac rhythm, conduction, and arrhythmias were determined. The activity of superoxide dismutase, catalase, gutathione reductase, and glutathione peroxidase as well as the content of reduced and oxidized glutathione were measured. The relative contribution of the ROS-generating systems was assessed by inhibition of mitochondrial complexes I and III (rotenone and myxothiazol), NADPH oxidases (diphenylene iodonium and apocynine), and nitric oxide synthases (N-monomethyl-L-arginine and N-iminoethyl-L-ornithine). The effects of glycolysis inhibition (iodoacetate), glucose deprivation, glycogen depletion, and lactate accumulation were also investigated. In untreated hearts, ROS production peaked at 10.8 ± 3.3, 9 ± 0.8, and 4.8 ± 0.4 min (means ± SD; n = 4) of reoxygenation in the atria, ventricle, and outflow tract, respectively, and was associated with arrhythmias. Functional recovery was complete after 30-40 min. At reoxygenation, 1) the respiratory chain and NADPH oxidases were the main sources of ROS in the atria and outflow tract, respectively; 2) glucose deprivation decreased, whereas glycogen depletion increased, oxidative stress; 3) lactate worsened oxidant stress via NADPH oxidase activation; 4) glycolysis blockade enhanced ROS production; 5) no nitrosative stress was detectable; and 6) the glutathione redox cycle appeared to be a major antioxidant system. Thus, the glycolytic pathway plays a predominant role in reoxygenation-induced oxidative stress during early cardiogenesis. The relative contribution of mitochondria and extramitochondrial systems to ROS generation varies from one region to another and throughout reoxygenation.</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>21193588</pmid><doi>10.1152/ajpheart.00827.2010</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6135 |
ispartof | American journal of physiology. Heart and circulatory physiology, 2011-03, Vol.300 (3), p.H820-H835 |
issn | 0363-6135 1522-1539 |
language | eng |
recordid | cdi_proquest_miscellaneous_855200251 |
source | MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Antioxidants Chick Embryo Electron Transport Complex I - antagonists & inhibitors Electron Transport Complex I - metabolism Electron Transport Complex III - antagonists & inhibitors Electron Transport Complex III - metabolism Embryos Glucose Glycogen - metabolism Glycolysis - drug effects Glycolysis - physiology Heart Heart - drug effects Heart - physiopathology Hypoxia - drug therapy Hypoxia - metabolism Hypoxia - physiopathology Iodoacetates - pharmacology Lactates - metabolism Metabolism Methacrylates - pharmacology Mitochondria, Heart - drug effects Mitochondria, Heart - metabolism Mitochondria, Heart - physiology Myocardium - metabolism NADPH Oxidases - antagonists & inhibitors NADPH Oxidases - metabolism NADPH Oxidases - physiology NG-Nitroarginine Methyl Ester - pharmacology Ornithine - analogs & derivatives Ornithine - pharmacology Oxidative stress Oxidative Stress - drug effects Oxidative Stress - physiology Poultry Reactive Oxygen Species - metabolism Reperfusion Injury - drug therapy Reperfusion Injury - metabolism Reperfusion Injury - physiopathology Rotenone - pharmacology Thiazoles - pharmacology |
title | Differential contribution of mitochondria, NADPH oxidases, and glycolysis to region-specific oxidant stress in the anoxic-reoxygenated embryonic heart |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A41%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differential%20contribution%20of%20mitochondria,%20NADPH%20oxidases,%20and%20glycolysis%20to%20region-specific%20oxidant%20stress%20in%20the%20anoxic-reoxygenated%20embryonic%20heart&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Raddatz,%20Eric&rft.date=2011-03&rft.volume=300&rft.issue=3&rft.spage=H820&rft.epage=H835&rft.pages=H820-H835&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.00827.2010&rft_dat=%3Cproquest_cross%3E2285018821%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=855297985&rft_id=info:pmid/21193588&rfr_iscdi=true |